.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 7,615,545

« Back to Dashboard
Patent 7,615,545 protects SEASONIQUE and LOSEASONIQUE and is included in two NDAs. There have been zero Paragraph IV challenges on LoSeasonique and Seasonique There is one tentative approval for the compound protected by this patent. Additional details are available via the generic ingredient links below.

This patent has thirty-two patent family members in twenty countries.

Summary for Patent: 7,615,545

Title:Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
Abstract:This invention relates to a method of preventing pregnancy and treating PMS including PMDD. More particularly, the invention relates to a method, which involves administering one of several combination oral contraceptive regimens in combination with an antidepressant and a kit containing the same.
Inventor(s): Bell; Robert G. (Palm Harbor, FL), Ben-Maimon; Carole (Merion, PA), Iskold; Beata (Livingston, NJ)
Assignee: Duramed Pharmaceuticals, Inc. (Pomona, NY)
Application Number:11/892,014
Patent Claim Types:
see list of patent claims
Use; Delivery; Composition;
Patent Metrics:
Source: PatentQuant.com
Field: Pharmaceuticals
Back Citations: 74th percentile
Forward Citations: 1st percentile

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Teva Branded Pharm
SEASONIQUE
ethinyl estradiol; levonorgestrel
TABLET;ORAL021840-001May 25, 2006RXYes7,615,545► subscribe PREVENTION OF PREGNANCY
Teva Branded Pharm
LOSEASONIQUE
ethinyl estradiol; levonorgestrel
TABLET;ORAL022262-001Oct 24, 2008RXNo7,615,545► subscribe PREVENTION OF PREGNANCY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: 7,615,545

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,680,084Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology► subscribe
7,320,969Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology► subscribe
7,858,605Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 7,615,545

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Japan2005516913► subscribe
Japan2010180236► subscribe
Japan2012107052► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc